BAFNA PHARMACEUTICALS
Back to Income Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹11 Cr | ₹5.22 Cr | ₹5.83 Cr | ₹-25 Cr | ₹-20 Cr |
What is the latest Consolidated Net Profit of BAFNA PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹11 Cr |
Mar2022 | ₹5.22 Cr |
Mar2021 | ₹5.83 Cr |
Mar2020 | ₹-25 Cr |
Mar2019 | ₹-20 Cr |
How is Consolidated Net Profit of BAFNA PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹11 Cr | 117.33 | |
Mar2022 | ₹5.22 Cr | -10.47 | |
Mar2021 | ₹5.83 Cr | Positive | |
Mar2020 | ₹-25 Cr | Negative | |
Mar2019 | ₹-20 Cr | - |
Compare Consolidated Net Profit of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹253.0 Cr | 16.9% | 31.2% | -1.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | 16.9% |
31.2% |
-1.1% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses